FKBP5 rs11586632: Genetic Variation and Stress Response
The single-nucleotide polymorphism rs11586632 is an intronic DNA variant located within the FKBP5 locus on chromosome 6. Functional genomic studies classify it as a stress-interactive expression quantitative trait locus (eQTL), meaning its influence on regional gene regulation emerges primarily in the presence of severe physiological stress or glucocorticoid exposure rather than in baseline states. While investigated in psychiatric genetics and stress neurobiology, the direct clinical evidence linking this specific variant to health outcomes remains limited.
What each genotype means
Typical stress response profile
This genotype is considered the common baseline for this variant. Research suggests that individuals with this profile typically maintain standard glucocorticoid receptor sensitivity, though individual stress responses remain influenced by a complex interplay of environmental factors and other genetic markers.
Carried by approximately 40-45% of individuals in European populations.
Altered stress signaling potential
Carrying one copy of the T allele may modulate how your body regulates cortisol and responds to stress. Studies indicate that this variant can influence FKBP5 gene expression, potentially affecting neuroendocrine feedback loops, though the clinical significance varies significantly based on your personal history of trauma and environmental context.
Carried by approximately 40-45% of individuals in European populations.
Heightened stress sensitivity potential
This genotype is associated with potential changes in FKBP5-mediated glucocorticoid receptor sensitivity, which may influence how your nervous system recovers from stress. Research suggests that in the presence of significant lifetime trauma, this profile may be linked to altered HPA axis regulation; please discuss any concerns regarding stress management or mental health with a qualified clinician.
Carried by approximately 10-15% of individuals in European populations.
What Is rs11586632 and Where Does It Sit?
The variant rs11586632 represents a single-nucleotide substitution on human chromosome 6 (specifically within cytogenetic band 6p21.31). It involves an exchange between guanine (G) and adenine (A) alleles. Located within an intronic, non-coding region of the FKBP5 genomic landscape, rs11586632 does not alter the amino acid sequence of the encoded protein. Instead, variants within this non-coding neighborhood frequently lie near or within regulatory elements, such as hormone-response binding sites or chromatin looping regions. In computational and molecular expression mapping, rs11586632 is recognized as an expression quantitative trait locus (eQTL). Rather than operating as a conventional "base" eQTL that alters transcript levels under standard resting conditions, rs11586632 demonstrates an interactive profile: the correlation between genotype and transcriptional activity shifts significantly under environmental pressure or glucocorticoid stimulation.
The Biology of FKBP5 and Glucocorticoid Signaling
The FKBP5 gene encodes the FK506 binding protein 51 (FKBP51), a co-chaperone protein that plays an indispensable role in regulating the body's primary stress-response mechanism, the hypothalamic-pituitary-adrenal (HPA) axis. FKBP51 directly forms a molecular complex with heat shock protein 90 (HSP90) and the glucocorticoid receptor (GR). When bound to this heterocomplex, FKBP51 reduces the receptor's affinity for cortisol and retards its translocation into the cell nucleus, acting as a brake on glucocorticoid signaling. Under typical physiological conditions, cortisol release activates the glucocorticoid receptor, which rapidly triggers transcription of FKBP5 as part of an ultra-short negative feedback loop. Elevated FKBP51 then dampens further receptor activation, helping the stress response return to equilibrium. When genetic variants alter the efficiency, responsiveness, or epigenetic remodeling of this feedback cycle, tissues can become either chronically resistant or hypersensitive to glucocorticoid exposure.
What Published Research Associates rs11586632 With
Variants across the FKBP5 locus have been extensively studied in neuropsychiatric genetics, particularly concerning gene-environment (G×E) interactions involving childhood trauma, chronic life adversity, major depressive disorder, and post-traumatic stress disorder (PTSD). In post-mortem brain tissue studies and cellular glucocorticoid challenge assays, rs11586632 specifically emerged as a stress-interactive regulatory variant. For example, functional transcriptomic analyses in regions such as the dorsal anterior cingulate cortex (dACC) demonstrate that gene expression patterns correlate with rs11586632 genotype primarily as traumatic stress burden accumulates. However, the direct epidemiological evidence specifically isolated to rs11586632 is currently classified as limited. Much of the historical psychiatric literature has centered on better-known neighboring tag SNPs within the same linkage disequilibrium block, such as rs1360780 and rs3800373. Because large genome-wide association studies (GWAS) often yield inconsistent effect sizes across differing ancestral cohorts and trauma definitions, rs11586632 should be viewed as a biological modifier of cellular stress dynamics rather than an established risk determinant.
Population Frequency Across Ancestries
The rs11586632 polymorphism is a common variant observed globally across diverse populations in the Genome Aggregation Database (gnomAD) and the 1000 Genomes Project. In European populations, the minor allele (A) occurs at a frequency of approximately 0.35. Because both alleles are broadly distributed in world populations, millions of healthy individuals carry one or two copies of the minor allele without developing any psychiatric conditions or neuroendocrine dysfunction. Allele distributions can vary between continental populations, underscoring that gene-environment studies conducted in one ancestry group cannot be assumed to apply uniformly across individuals of differing backgrounds.
What You Can and Cannot Do With This Information
Discovering your rs11586632 genotype provides an interesting window into the molecular mechanisms of stress neurobiology, but it does not function as a predictive or diagnostic medical test. It does not indicate that you have—or will develop—a mood disorder, anxiety, PTSD, or glucocorticoid insensitivity. Complex traits are shaped by hundreds of genetic loci interacting alongside lifelong experiences, psychological resilience, social support systems, and physical environment. Furthermore, while FKBP5 interacts biochemically with corticosteroid pathways and has been investigated in relation to antidepressant efficacy, rs11586632 cannot be used to guide prescription choices. You should never initiate, discontinue, or alter dosages of psychiatric medications or corticosteroid therapies based on consumer genetic readouts. Any decisions regarding medication management or stress-related symptoms must always be discussed directly with a qualified physician or clinical pharmacist.
How common is this variant?
The minor A allele occurs at a frequency of approximately 0.35 in populations of European ancestry and is widely present across global cohorts cataloged in gnomAD. Consequently, heterozygous (AG) and homozygous (AA) genotypes are observed in millions of healthy individuals worldwide.
Frequently asked questions
Does having the AA genotype mean I will develop PTSD or depression?
No. Genetic variants in FKBP5 such as rs11586632 do not cause psychiatric disorders. Mental health conditions arise from an intricate interplay of life experiences, social context, coping mechanisms, and thousands of distinct genetic factors.
Can this genetic test show if I am more sensitive to stress?
While rs11586632 has been characterized as a stress-interactive regulatory variant at the cellular level, these findings reflect statistical molecular patterns in research cohorts rather than individual behavioral outcomes. Carrying a specific genotype does not mean you handle real-world challenges any better or worse than someone else.
Can my rs11586632 genotype tell my doctor which antidepressant or steroid to prescribe?
No. Variant rs11586632 is not recognized by pharmacogenomic bodies such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) or PharmGKB as an actionable prescribing marker. Always consult your prescribing clinician or pharmacist before altering any medical treatment.
How was the association between rs11586632 and stress discovered?
Researchers combined genomic sequencing with tissue expression profiling (eQTL analysis) and cellular exposure to cortisol or documented trauma scores. They identified that rs11586632 altered downstream gene transcription only when elevated stress hormones or significant life trauma were present.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11586632?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FKBP5
This intronic variant in the FKBP5 gene modulates glucocorticoid receptor sensitivity and is linked to altered stress reactivity and susceptibility to psychiatric conditions like PTSD and depression.
Intronic variant in FKBP5; while FKBP5 is a well-established stress-response gene, specific associations for rs4713919 with HPA axis dynamics are less robustly replicated than other variants like rs1360780.
Modulates FKBP5 chaperone expression and alters glucocorticoid receptor sensitivity and negative feedback regulation of the HPA axis.
Regulatory variant in FKBP5 affecting glucocorticoid receptor chaperone activity and susceptibility to stress-related neuropsychiatric outcomes.
Functional polymorphism in FKBP5 that modulates ultradian and stress-induced cortisol secretion and alters recovery trajectories following acute psychological stress.
Intronic regulatory variant within FKBP5 linked to altered glucocorticoid receptor sensitivity and acute cortisol response following psychosocial stress.